Navigation Links
Reportlinker Adds China Cardiovascular Devices Market Outlook to 2016
Date:6/1/2010

>8.3 Secondary Research 68

8.4 Primary Research 68

8.5 Models 69

8.6 Forecasts 69

8.7 Expert Panels 69

8.8 GlobalData Consulting 69

8.9 Currency Conversion 70

8.10 Contact Us 70

8.11 Disclaimer 70

1.1 List of Tables

Table 1: Cardiovascular Devices, China, Overall Revenue ($m), 2002-2016 19

Table 2: Cardiovascular Devices Market, China, Category Contribution (%), 2009 21

Table 3: Cardiovascular Devices, China, Cross-Category Analysis, 2002-2016 22

Table 4: Cardiovascular Devices, China, Overall Revenue ($m), Historic, 2002-2009 24

Table 5: Cardiovascular Devices, China, Overall Revenue ($m), Forecast, 2009-2016 26

Table 6: Cardiovascular Devices, China, Category Volume (Units), 2002-2016 27

Table 7: Cardiovascular Devices, China, Category Volume (Units), Historic, 2002-2009 29

Table 8: Cardiovascular Devices, China, Category Volume (Units), Forecast, 2009-2016 31

Table 9: Cardiovascular Devices, China, Company Share by Revenue ($m), 2008-2009 33

Table 10: Cardiac Rhythm Management Market, China, Category Contribution (%), 2009 36


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Reportlinker Adds Medical Device Distributors - Europe
2. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
3. Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry
4. Reportlinker Adds Global HIV Drugs industry
5. Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets
6. Reportlinker Adds Antifungal Drugs: Technologies and Global Markets
7. Reportlinker Adds The World Anesthesia Drug Market
8. Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence
9. Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025
10. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
11. Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... LONDON , BERLIN ... Arthroscopy Devices Market to ... for Minimally Invasive Procedures to Drive Future Growth" looks ... for the six arthroscopy device market segments: arthroscopes, arthroscopy ... radio frequency systems, and arthroscopy visualization systems. The report ...
(Date:5/20/2013)...  TNI BioTech, Inc. (OTCQB: TNIB), a biotech company ... the body,s immune system using patented immunotherapy, announced its common ... under the ticker symbol "TNIB" commencing May 17, 2013. Investors ... stock quotes for TNIB at http://www.otcmarkets.com/stock/TNIB/quote . ... TNI BioTech, Inc. stated, "We are very pleased to ...
(Date:5/20/2013)... , May 20, 2013  Neuralstem, Inc. (NYSE MKT: ... , MD, PhD, principal investigator, presented updated Phase I ... (NSI-566) trial in the treatment of amyotrophic lateral sclerosis ... at the neuro diabetes special medical symposium in ... talk called "Recent Therapeutic Advances in Stem Cell Therapy," ...
Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
... July 27, 2011 HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) ... six months ended June 30, 2011, after the close of ... A conference call with management is scheduled for 5:00 ... (being 7:00 am Australian Eastern Standard Time, Friday, August 5, ...
... July 27, 2011 Stryker Neurovascular, a division of ... and Platinum Science (MAPS) Trial during the Society of ... The MAPS Trial establishes a new standard for the ... (TAR)*, and proves that coiling is an excellent treatment ...
Cached Medicine Technology:HeartWare to Report Financial Results for Second Quarter of 2011 2Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms 2Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms 3
(Date:5/20/2013)... 20, 2013 A pioneer and ... solutions, i2i Systems announced today that ... Foundation (SCF) selected i2iTracks as their population management ... meet their Meaningful Use (MU), Government Performance and ... requirements – a welcomed solution to managing the ...
(Date:5/20/2013)... T.E.N. announced today that it ... Information Security Executive® Northeast Awards now through Friday, ... Information Security Executive® of the Year and ISE® ... made a positive impact on their organizations through ... information security; and the ISE® Project of the ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 6Webs.com is ... alarm system reviews . 6Webs.com recently completed their assessments ... nation. Reviews are completed annually and the top home ... which include their monitoring technology, equipment and warranties to ... stated, "When the 6Webs.com team completed the home security ...
(Date:5/20/2013)... NV (PRWEB) May 20, 2013 WEDI, ... to improve the exchange of healthcare information, announced today ... creation of the WEDI ICD-10 State Collaborative Initiative. The ... their members in order to increase efficiencies and reduce ... , The goal of the new initiative is to ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Selexis SA, ... lead identification and cell line development for scale-up and ... Company’s co-founder will present data on the Company’s core ... & Engineering Conference, May 20 - 23 at the ... California. Selexis’ co-founder and scientific advisory board member, Nicolas ...
Breaking Medicine News(10 mins):Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 2Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 3Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 2Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 3Health News:Best Home Alarm System Companies in 2013 Published by Leading Security Reviews Site - 6Webs.com 2Health News:WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3
... Reporter , THURSDAY, Jan. 5 (HealthDay News) -- Pediatric ... to lower the threshold for toxic lead exposure in ... and house paint, can permanently damage developing brains. ... Poisoning Prevention voted to recommend that the federal government ...
... of patients with mild-to-moderate asthma have persistently non-eosinophilic ... anti-inflammatory treatments, according to a new study. ... enrolled in nine clinical trials conducted by the ... eosinophils) was,found in only 36% of asthmatics not ...
... Mozes HealthDay Reporter , THURSDAY, Jan. 5 ... double their risk of developing a particularly advanced form ... large new European study suggests. The possible link ... (AMD), a significant cause of blindness in seniors. ...
... Proton therapy, a type of external beam radiation therapy, ... according to two new studies published in the January ... (Red Journal), the American Society for Radiation Oncology,s ... study, researchers at the University of Florida in Jacksonville, ...
... Jan. 5 (HealthDay News) -- Children and young adults ... for complications from the flu and should receive flu ... in Ohio in February 2011. Of the 130 ... young adults with neurological and neurodevelopmental conditions, 76 (58 ...
... cost paid for statins (drugs to lower cholesterol) in ... insurance is approximately 400 percent higher than comparable costs ... These findings, from the Boston University School of Medicine ... results of a comprehensive comparison of prescription drug costs ...
Cached Medicine News:Health News:Experts Endorse Lower Lead-Poisoning Threshold 2Health News:Experts Endorse Lower Lead-Poisoning Threshold 3Health News:A large subgroup of mild-to-moderate asthma is persistently non-eosinophilic 2Health News:Could Daily Aspirin Harm Seniors' Eyes? 2Health News:Could Daily Aspirin Harm Seniors' Eyes? 3Health News:Proton therapy effective prostate cancer treatment 2Health News:Study finds statin costs 400 percent higher in US compared to UK 2
... TM-1 is a compact multi-functional ... precise measurement of UVA, UVB, ... all types of lens materials. ... connect with a personal computer ...
... This sleek, contoured instrument table ... room dcor, while providing a sturdy, ... wheelchair compatible design provides completely open ... make positioning quick and easy. The ...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... corrected curve trial lenses are ground with the ... refractors and are invaluable in treating low vision ... manufacturers contain a disproportionately large number of lenses ... to produce, and fewer lenses in the higher ...
Medicine Products: